Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?
Alzheimer’s disease (AD) is an aging-related neurodegenerative disease, leading to the progressive loss of memory and other cognitive functions. As there is still no cure for AD, the growth in the number of susceptible individuals represents a major emerging threat to public health. Currently, the p...
Main Authors: | Chunyuan Yin, Amy C. Harms, Thomas Hankemeier, Alida Kindt, Elizabeth C. M. de Lange |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/5/4960 |
Similar Items
-
Application of Metabolomics in Alzheimer’s Disease
by: Jordan Maximillian Wilkins, et al.
Published: (2018-01-01) -
Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer’s Disease
by: Ruchika Bhawal, et al.
Published: (2021-12-01) -
Metabolomics in the Development and Progression of Dementia: A Systematic Review
by: Yanfeng Jiang, et al.
Published: (2019-04-01) -
Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
by: Sumeyya Akyol, et al.
Published: (2021-09-01) -
Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy
by: Patricia Ancel, et al.
Published: (2023-07-01)